|
SRPK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.227410E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.657500E-03 |
| Normal-vs-Stage2 |
2.556500E-02 |
| Normal-vs-Stage3 |
1.812180E-04 |
| Normal-vs-Stage4 |
4.837600E-03 |
| Stage1-vs-Stage2 |
5.952600E-01 |
| Stage1-vs-Stage3 |
8.592400E-02 |
| Stage1-vs-Stage4 |
3.408800E-01 |
| Stage2-vs-Stage3 |
4.789600E-01 |
| Stage2-vs-Stage4 |
7.666400E-01 |
| Stage3-vs-Stage4 |
6.693400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.554010E-04 |
| Normal-vs-AfricanAmerican |
6.399200E-03 |
| Normal-vs-Asian |
8.881600E-01 |
| Caucasian-vs-AfricanAmerican |
4.516000E-01 |
| Caucasian-vs-Asian |
3.511800E-01 |
| AfricanAmerican-vs-Asian |
2.901800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.572600E-04 |
| Normal-vs-Female |
8.571900E-04 |
| Male-vs-Female |
8.517400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.423400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.917100E-03 |
| Normal-vs-Age(61-80Yrs) |
7.92990000000326E-05 |
| Normal-vs-Age(81-100Yrs) |
2.06619999999491E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.308000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.182200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.169700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.465200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.120200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.140100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.451000E-01 |
| Normal-vs-Grade 2 |
3.583200E-03 |
| Normal-vs-Grade 3 |
1.96510999999067E-05 |
| Normal-vs-Grade 4 |
1.965900E-02 |
| Grade 1-vs-Grade 2 |
2.363600E-01 |
| Grade 1-vs-Grade 3 |
6.619600E-02 |
| Grade 1-vs-Grade 4 |
2.524200E-01 |
| Grade 2-vs-Grade 3 |
1.196980E-01 |
| Grade 2-vs-Grade 4 |
6.799000E-01 |
| Grade 3-vs-Grade 4 |
5.537000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.838700E-04 |
| Normal-vs-ccB subtype |
1.094830E-01 |
| ccA subtype-vs-ccB subtype |
6.226300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.098000E-03 |
| Normal-vs-N1 |
9.058200E-01 |
| N0-vs-N1 |
3.630000E-01 |
|
|
